We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

44 hedge funds and large institutions have $126M invested in Protara Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

8% less funds holding

Funds holding: 48 → 44 (-4)

22% less capital invested

Capital invested by funds: $161M → $126M (-$34.7M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.23%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.14%
New
2
Increased
12
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$1.51M
2
MIM
Monashee Investment Management
Massachusetts
+$1.19M
3
Northern Trust
Northern Trust
Illinois
+$947K
4
BIT
BlackRock Institutional Trust
California
+$120K
5
State Street
State Street
Massachusetts
+$113K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$448K
2
TC
TFS Capital
Pennsylvania
-$377K
3
SIM
Spark Investment Management
New York
-$269K
4
Morgan Stanley
Morgan Stanley
New York
-$60.1K
5
RFC
Russell Frank Company
Washington
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$27.4M – – –
RCM
2
RA Capital Management
Massachusetts
$21M – – –
DM
3
Deerfield Management
New York
$17.6M – – –
MAM
4
MPM Asset Management
Massachusetts
$13.7M – – –
Fidelity Investments
5
Fidelity Investments
Massachusetts
$11.8M – – –
TAM
6
Tiverton Asset Management
Delaware
$5.22M – – –
DVC
7
Deer VII & Co
New York
$4.38M – – –
PA
8
Perceptive Advisors
New York
$3.83M – – –
BBA
9
Baker Bros. Advisors
New York
$3.82M +$1.51M +2,446 +55%
OFM
10
Omega Fund Management
Massachusetts
$3.48M – – –
BFA
11
BlackRock Fund Advisors
California
$2.77M +$93.5K +151 +3%
Principal Financial Group
12
Principal Financial Group
Iowa
$2.54M +$38.4K +62 +1%
Vanguard Group
13
Vanguard Group
Pennsylvania
$2.03M -$448K -723 -17%
Northern Trust
14
Northern Trust
Illinois
$1.08M +$947K +1,529 +369%
MIM
15
Monashee Investment Management
Massachusetts
$1.07M +$1.19M +1,928 New
State Street
16
State Street
Massachusetts
$758K +$113K +183 +15%
BIT
17
BlackRock Institutional Trust
California
$700K +$120K +194 +18%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$579K +$18.6K +30 +3%
BIM
19
BlackRock Investment Management
Delaware
$353K -$7.43K -12 -2%
TCIM
20
TIAA CREF Investment Management
New York
$276K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$274K -$27.2K -44 -8%
MPM
22
Meritage Portfolio Management
Kansas
$199K – – –
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$196K – – –
KCM
24
Kornitzer Capital Management
Kansas
$167K -$46.4K -75 -20%
BCM
25
Bridgeway Capital Management
Texas
$165K – – –
1
2

TARA Hedge Fund Activity: Q3 2015 in Review

44 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2015, worth a combined $126M — down 22% from $161M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TARA and 2 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $1.51M. The largest seller was Vanguard Group, cutting an estimated $448K.

  • 44 institutional investors held Protara Therapeutics (TARA) as of Q3 2015, down from 48 in Q2 2015.
  • Funds reported $126M of Protara Therapeutics stock for Q3 2015, down 22% quarter-over-quarter.
  • 2 funds opened new Protara Therapeutics positions in Q3 2015 and 6 closed out, a net change of -4 holders.
  • The largest Protara Therapeutics buyer in Q3 2015 was Baker Bros. Advisors, an estimated $1.51M added.
  • The largest Protara Therapeutics seller in Q3 2015 was Vanguard Group, an estimated $448K sold.

Based on aggregated 13F filings for Q3 2015.